Leverkusen, Nordrhein-Westfalen, Germany Bayer is the famous Corporate Investor, which was founded in 1863. The main office of represented Corporate Investor is situated in the Leverkusen. The fund was located in Europe if to be more exact in Germany.
Among the most popular portfolio startups of the fund, we may highlight BlueRock Therapeutics, OneDrop, Arvegenix. Among the most popular fund investment industries, there are Biotechnology, Agriculture. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Bayer, startups are often financed by Launch Fund, The Yield Lab, St. Louis Arch Angels. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, Ginkgo Bioworks, ARCH Venture Partners. In the next rounds fund is usually obtained by Viking Global Investors, Ginkgo Bioworks.
Deals in the range of 50 - 100 millions dollars are the general things for fund. Speaking about the real fund results, this Corporate Investor is 38 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2019. When the investment is from Bayer the average startup value is 5-10 millions dollars. Comparing to the other companies, this Bayer performs on 21 percentage points less the average number of lead investments. The top amount of exits for fund were in 2019.
This organization was formed by Friedrich Bayer, Johann Friedrich Weskott.
Related Funds
| Fund Name | Location |
| Aligned Partners | California, Menlo Park, United States |
| Bethesda venture capital | - |
| Citizen's Capital | Boston, Massachusetts, United States |
| CKD Venture Capital Corporation | Seoul, Seoul-t'ukpyolsi, South Korea |
| Exponential Partners | California, Corona Del Mar, United States |
| Falcon Edge India | Cayman Islands, Grand Cayman |
| Hella Ventures | California, Sunnyvale, United States |
| Highland Creek Partners | Canada, Ontario, Toronto |
| Huabin Venture Capital | China, Shanghai |
| Koudai Information Technology | China, Hangzhou, Zhejiang |
| Linic Ltd | - |
| m-pathy | Dresden, Germany, Sachsen |
| New York Life Investment Management | New York, New York, United States |
| Northwest Ohio Tech Fund II | - |
| Phoenix Tree Capital Partners | Beijing, Beijing, China |
| Seiho Investment Works | Hokkaido Prefecture, Japan, Sapporo |
| Shanghai Lemeng Shiye Co., Ltd | China, Shanghai |
| Sino AG | - |
| Vista Venture Partners | California, Palo Alto, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
OME Health | 20 Jun 2022 | London, England, United Kingdom | |||
OneDrop | $34M | 24 Aug 2020 | New York, United States | ||
Okko Health | $394K | 01 Jan 2020 | England | ||
Immunitas Therapeutics | $39M | 21 Nov 2019 | Cambridge, Massachusetts, United States | ||
Litesprite | 10 Nov 2019 | Bellevue, Washington, United States | |||
EGenesis | $100M | 07 Nov 2019 | Cambridge, Massachusetts, United States | ||
Huma | $50M | 05 Nov 2019 | London, England, United Kingdom | ||
Upside Health | $200K | 10 Oct 2019 | New York, New York, United States | ||
OneDrop | $40M | 17 Sep 2019 | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
OME Health | 20 Jun 2022 | London, England, United Kingdom | |||
OneDrop | $34M | 24 Aug 2020 | New York, United States | ||
Okko Health | $394K | 01 Jan 2020 | England | ||
Immunitas Therapeutics | $39M | 21 Nov 2019 | Cambridge, Massachusetts, United States | ||
Litesprite | 10 Nov 2019 | Bellevue, Washington, United States | |||
EGenesis | $100M | 07 Nov 2019 | Cambridge, Massachusetts, United States | ||
Huma | $50M | 05 Nov 2019 | London, England, United Kingdom | ||
Upside Health | $200K | 10 Oct 2019 | New York, New York, United States | ||
OneDrop | $40M | 17 Sep 2019 | New York, New York, United States |
